Exelon憶思能

Exelon Use In Pregnancy & Lactation

rivastigmine

Manufacturer:

Novartis

Distributor:

Zuellig
/
Four Star
Full Prescribing Info
Use In Pregnancy & Lactation
Women of Child-Bearing Potential: There is no information available on the effects of rivastigmine in women of child-bearing potential.
Pregnancy: In animal studies, rivastigmine was not teratogenic. However, the safety of Exelon in human pregnancy has not been established, and it should only be given to pregnant women if the potential benefit outweighs the potential risk for the foetus.
Breast-feeding: In lactating animals, rivastigmine and/or metabolites were excreted in breast milk. It is not known if Exelon is excreted into human milk, and patients on Exelon should therefore not breast-feed.
Fertility: There is no information available on the effects of rivastigmine on human fertility.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in